 |
|
|
|
Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
| A | SHV-1 | 1ONG | 1.10 | 2003-12-09 | P14557 | 14609325 | 10.1021/BI034986B | pdb | *WY4 MA4 | P 21 21 21 | 49.555 55.183 85.315 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 1Q2P | 2.00 | 2004-09-14 | P14557 | 15588091 | 10.1021/JM049680X | pdb | *WY2 MA4 | P 21 21 21 | 49.532 55.105 84.154 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 1RCJ | 1.63 | 2004-02-17 | P14557 | 14744126 | pdb | E166A | *TBI MA4 | P 21 21 21 | 49.848 55.193 83.733 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 1SHV | 1.98 | 1999-05-06 | P14557 | 10231522 | 10.1021/BI990136D | pdb | MA4 | P 21 21 21 | 49.600 55.600 87.000 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 1TDG | 1.80 | 2004-11-23 | P14557 | 15518561 | 10.1021/BI0487903 | pdb | S130G | *TBE MA4 MDD MPD MRD | P 21 21 21 | 49.834 55.255 83.571 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 1TDL | 1.80 | 2004-11-23 | P14557 | 15518561 | 10.1021/BI0487903 | pdb | S130G | EPE MA4 | P 21 21 21 | 49.608 55.301 84.080 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 1VM1 | 2.02 | 2004-09-07 | Q9F643 | 11327849 | 10.1021/BI0022745 | pdb | $TAZ *AKR *TBE MA4 | P 21 21 21 | 49.200 56.100 82.500 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 2A3U | 1.34 | 2005-08-02 | P14557 | 16055923 | 10.1074/JBC.M505333200 | pdb | E166A | *TSL EPE MA4 | P 21 21 21 | 49.510 55.310 83.730 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 2A49 | 1.43 | 2005-08-02 | P14557 | 16055923 | 10.1074/JBC.M505333200 | pdb | E166A | *TEM EPE MA4 | P 21 21 21 | 49.630 55.200 84.710 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 2G2U | 1.60 | 2006-07-04 | P0AD64 | 16809340 | 10.1074/JBC.M603878200 | pdb | P 63 | 127.871 127.871 73.400 ♦ 90.00 90.00 120.00 | 6 | ||
| A | SHV-1 | 2G2W | 1.80 | 2006-07-04 | P0AD64 | 16809340 | 10.1074/JBC.M603878200 | pdb | D104K | P 1 | 42.563 44.825 62.902 ♦ 78.88 88.94 62.42 | 1 | |
| A | SHV-1 | 2H0T | 1.60 | 2007-01-30 | Q5PSW7 | 17002290 | 10.1021/BI060990M | pdb | E166A M69V | *TEM EPE MA4 | P 21 21 21 | 49.680 55.200 83.490 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 2H0Y | 1.70 | 2007-01-30 | P0AD64 | 17002290 | 10.1021/BI060990M | pdb | E166A M69V | *TSL ESA MA4 | P 21 21 21 | 49.590 55.310 83.630 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 2H10 | 1.75 | 2007-01-30 | P0AD64 | 17002290 | 10.1021/BI060990M | pdb | E166A M69V | *TBE MA4 | P 21 21 21 | 49.670 55.180 83.530 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 2H5S | 1.28 | 2006-10-17 | Q5PSW7 | 17017804 | 10.1021/JA063715W | pdb | *SA2 MA4 | P 21 21 21 | 49.810 55.220 84.430 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 2ZD8 | 1.05 | 2008-09-30 | P0AD64 | 18761444 | 10.1021/JA7111146 | pdb | *MER MA4 | P 21 21 21 | 49.291 54.979 85.630 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3C4O | 1.70 | 2008-05-27 | P0AD64 | 18775544 | 10.1016/J.JMB.2008.05.051 | pdb | SO4 | P 63 | 127.233 127.233 73.417 ♦ 90.00 90.00 120.00 | 6 | |
| A | SHV-1 | 3C4P | 1.75 | 2008-05-27 | P0AD64 | 18775544 | 10.1016/J.JMB.2008.05.051 | pdb | SO4 | P 63 | 127.476 127.476 73.410 ♦ 90.00 90.00 120.00 | 6 | |
| A | SHV-1 | 3D4F | 1.55 | 2009-02-10 | P0AD64 | 18955486 | 10.1074/JBC.M806833200 | pdb | *LN1 MA4 | P 21 21 21 | 49.611 55.503 83.502 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3MKE | 1.75 | 2010-11-24 | P0AD64 | 21041505 | 10.1128/AAC.00930-10 | pdb | $CZ6 *CB4 MA4 | P 21 21 21 | 49.554 56.484 82.067 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3MKF | 1.33 | 2010-11-24 | P0AD64 | 21041505 | 10.1128/AAC.00930-10 | pdb | *CZ7 MA4 | P 21 21 21 | 49.215 56.139 82.590 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3MXR | 1.30 | 2010-11-24 | P0AD64 | 21041505 | 10.1128/AAC.00930-10 | pdb | *CZ8 MA4 | P 21 21 21 | 49.587 55.639 83.036 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3MXS | 1.24 | 2010-11-24 | P0AD64 | 21041505 | 10.1128/AAC.00930-10 | pdb | *CZ9 MA4 | P 21 21 21 | 49.703 55.479 83.159 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 3N4I | 1.56 | 2011-03-09 | P0AD64 | 21294157 | 10.1002/PROT.22961 | pdb | D104E | P 63 | 127.850 127.850 73.183 ♦ 90.00 90.00 120.00 | 6 | |
| A | SHV-1 | 3OPH | 1.34 | 2011-07-13 | P0AD64 | 21357298 | 10.1128/AAC.01360-10 | pdb | R164S | EPE MA4 | P 21 21 21 | 48.777 55.635 83.848 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 3OPL | 1.80 | 2011-07-13 | P0AD64 | 21357298 | 10.1128/AAC.01360-10 | pdb | R164H | EPE MA4 | P 21 21 21 | 48.674 55.647 84.281 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 3OPP | 1.80 | 2011-07-13 | P0AD64 | 21357298 | 10.1128/AAC.01360-10 | pdb | R164S | *SA2 MA4 | P 21 21 21 | 49.547 55.230 83.655 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 3OPR | 1.65 | 2011-07-13 | P0AD64 | 21357298 | 10.1128/AAC.01360-10 | pdb | R164H | *SA2 MA4 | P 21 21 21 | 49.430 55.467 82.924 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 3V50 | 1.45 | 2012-08-08 | Q5PSW7 | 22438274 | 10.1002/CMDC.201200006 | pdb | S130G | *SA2 MA4 | P 21 21 21 | 49.671 55.479 83.620 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 3V5M | 1.30 | 2012-08-08 | Q5PSW7 | 22438274 | 10.1002/CMDC.201200006 | pdb | M69V | MA4 | P 21 21 21 | 49.481 55.225 83.893 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4FCF | 1.09 | 2012-12-26 | P0AD64 | 23252553 | 10.1021/JM301490D | pdb | K234R | MA4 TAU | P 21 21 21 | 49.631 55.416 83.951 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4FD8 | 1.52 | 2012-09-26 | P0AD64 | 22974281 | 10.1021/JA3073676 | pdb | S70C | MA4 | P 21 21 21 | 49.354 55.584 84.414 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4FH2 | 1.44 | 2012-09-26 | P0AD64 | 22974281 | 10.1021/JA3073676 | pdb | S70C | $0RN MA4 | P 21 21 21 | 48.971 55.585 84.739 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4FH4 | 1.09 | 2012-09-26 | P0AD64 | 22974281 | 10.1021/JA3073676 | pdb | MA4 | P 21 21 21 | 49.807 55.186 83.570 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4GD6 | 1.53 | 2013-07-31 | P0AD64 | 23145056 | 10.1371/JOURNAL.PONE.0049035 | pdb | *17K MA4 | P 21 21 21 | 49.639 55.576 83.351 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4GD8 | 1.60 | 2013-07-31 | P0AD64 | 23145056 | 10.1371/JOURNAL.PONE.0049035 | pdb | *MXF MA4 | P 21 21 21 | 49.394 55.460 83.649 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4GDB | 1.84 | 2013-07-31 | P0AD64 | 23145056 | 10.1371/JOURNAL.PONE.0049035 | pdb | *17O EPE MA4 | P 21 21 21 | 49.580 55.502 85.797 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4JPM | 1.14 | 2013-12-04 | P0AD64 | 24219313 | 10.1021/JA403598G | pdb | *1OG EPE MA4 | P 21 21 21 | 49.308 55.222 84.285 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4MBF | 1.54 | 2014-07-30 | P0AD64 | 24454944 | 10.1371/JOURNAL.PONE.0085892 | pdb | *2AW MA4 | P 21 21 21 | 49.517 55.197 84.042 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4MBH | 1.22 | 2014-07-30 | P0AD64 | 24454944 | 10.1371/JOURNAL.PONE.0085892 | pdb | E166A | *0RJ EPE MA4 | P 21 21 21 | 49.538 55.259 83.819 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4MBK | 1.46 | 2014-07-30 | P0AD64 | 24454944 | 10.1371/JOURNAL.PONE.0085892 | pdb | K234R | *SA2 MA4 | P 21 21 21 | 49.212 55.361 83.325 ♦ 90.00 90.00 90.00 | 4 |
| A | SHV-1 | 4R3B | 1.37 | 2015-01-21 | P0AD64 | 25536850 | 10.1021/BI501197T | pdb | *3GE MA4 | P 21 21 21 | 49.238 55.274 84.465 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 4ZAM | 1.42 | 2016-01-27 | P0AD64 | 26340563 | 10.1371/JOURNAL.PONE.0136813 | pdb | *NXL MA4 | P 21 21 21 | 49.398 55.295 85.366 ♦ 90.00 90.00 90.00 | 4 | |
| A | SHV-1 | 5EE8 | 1.54 | 2016-01-27 | P0AD64 | 26729491 | 10.1128/AAC.02643-15 | pdb | *ZXM MA4 | P 21 21 21 | 49.567 55.185 83.500 ♦ 90.00 90.00 90.00 | 4 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: January 08, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu